-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RyL7f0uKPgMlSaWZZHffcjy3zo/nOxNo2h4lOtfdstFbp6KmcTvsSuWDvHYRvq7S NwK4TaQtrrbmHsoU73iihQ== 9999999997-08-034644.txt : 20080805 9999999997-08-034644.hdr.sgml : 20080805 20080805115649 ACCESSION NUMBER: 9999999997-08-034644 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080805 DATE AS OF CHANGE: 20080805 20080805 20080805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/ CENTRAL INDEX KEY: 0000849636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330303583 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-16467 FILM NUMBER: 08990267 BUSINESS ADDRESS: STREET 1: 15241 BARRANCA PKWY CITY: IRVINE STATE: CA ZIP: 92718 BUSINESS PHONE: 7147273157 MAIL ADDRESS: STREET 1: 15241 BARRANCA PARKWAY CITY: IRVINE STATE: CA ZIP: 92718 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0W(#`@;V)J#3P\+TQI;F5A-IB M8&#@9&!@?L(`!.+E#*B`"8A9&#@.,"@@"7)",0.#,@,/+^,D!C9AR:@DWH0+ M3`M@FN2:H)JM@)B1@4$Z&D(SJ\--86-@T'L#$67D!P@P`#U3",P-"F5N9'-T M%LW(#0P72]$96-O9&5087)MPT*96YD6]U="]/;F5#;VQU;6XO4W1R=6-T5')E95)O;W0@-R`P M(%(O5'EP92]#871A;&]G+TQA;F%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\+T=3,"`U-R`P(%(^/CX^ M+U1Y<&4O4&%G93X^#65N9&]B:@TU,"`P(&]B:@T\/"]3=6)T>7!E+U1R=654 M>7!E+T9O;G1$97-C;S>IN/6S2.3=IMB9-;M+37;.S MJ$RKQZIDX(S!,@Q_D"&W8YLC<9`)+N^Q,LRL=^Y'T/H1B-!-2S?L?NQW]_/% M/=RHFJ_<3]?A:GV#H:Z7(D8)8340CL4A$,&VN4/HP6J^P"73/R"\7TS#6_PQ MZ)/?QE+C24=3D)P21K:L7[, MFFF88OAZ@X1C&I&(VCM!S#*HOU80/FI6NO08<7 MMLV$3CB]U"E+FA)8YSJ@DYKIVJX'&LR6OUC6Q#>&L=JV,W4KZ$'],_0W#-&V M%LJ(*66$Y]*3@=CO!.*<4>QV%(NF1*EXP(6:Y3G&&;VJK_085EU%DEQ6NZ.H M`0$Q:=$P1IYU5P]57"8Q%E3(`)++MSS!:.>;KM M2;\>E'ROHK+$.0:5\2%-2,9HI#I*"JS`!R1B1S50\"GP][EJ*@70K!WSES(< MRJ!CXZ)\I=4N%/(BP(J1.`S?UTH/$!GDA!9,Z..YJ)PDHNN)=P/2\Y(3BU;,BN MN:YI0_\Y\I*S&N?9ONZ>%'\4E01=K&$_J,18IM5[NC8T1Q M7B0H@.G+&%H-H>=A MX%,T@/I6GOC;F`H!)OSY!V%QN.G\RZ:3QV'[G?.P&?S_H_/`001W5SL(NCZ% M5D14L5M**5$M5&-.>Y%7CX?ZU><*TUO/XK(J1A;?)''H&X@U&*9E]D[P;UFL MMP?'<92?-?J66>LG),V:_/"68=GOGNK.CAPHPZ*&9B@>O*5*WGUC+GA-J];M MV/69TU6R5S=O4'>+,M2T8^RXHJSX^0`+=F"+,R9-NP;]VT)"4O(8B3-,Q0YY M0=G+A^%XG9_AS_TQ?^>[1M`Y*@\`9Y>H+Q%C%#[K,"=]W]IG[W/WV7N?M2X`)$\?+B\% ME@(@F2?@!WHXTU>%1]"Q_0`&>(`!I@`P6>FIOD'NP4`D+S<7>KK("?R+W@P! M2/R^9>CI3Z>#_T_2K%2^``#(7\3F;$XZ2\3Y(D[*%*2*[3,BIL8DBAE&B9DO M2E#$6\3BG%/9R6PQ]XAX>X:0(V+$1\0%&5Q.IHAO MBU@S29C,%?%;<6PRAYD.`(HDM@LXK'@1FXB8Q`\.=!'Q<@!PI+@O..8+%G"R M!.)#N:2D9O.YW(RDS@"@:$_DY7(Y+/I+BG)J4Q>-@"+ M9_XL&7%MZ:(B6YI:6UH:FAF9?E&H_[KX-R7N[2*]"OC<,XC6]X?MK_Q2Z@!@ MS(IJL^L/6\Q^`#JV`B!W_P^;YB$`)$5]:[_QQ7EHXGF)%PA2;8R-,S,SC;@< MEI&XH+_K?SK\#7WQ/2/Q=K^7A^[*B64*DP1T<=U8*4DI0CX]/97)XM`-_SS$ M_SCPK_-8&LB)Y?`Y/%%$J&C*N+PX4;MY;*Z`F\*C?!?W[KG")^)'. MC?LP`OB!8!`. MU@(6B`?)@`\R02[8#`I`$=@%]H)*4`/J02-H`2=`!S@-+H#+X#JX">Z`!V`$ MC(/G8`:\`?,0!&$A,D2!Y"%52`LR@,P@!F0/N4$^4"`4#D5#<1`/$D*YT!:H M""J%*J%:J!'Z%CH%78"N0@/0/6@4FH)^A=[#"$R"J;`RK`T;PPS8"?:&@^$U MT(%U(+W(+&4&FD7U"W4*&H&]0E-1BNA#=`V:"_T*G0<.A-=@"Y'-Z#;T)?0=]#CZ#<8#(:& MT<%883PQX9@$S#I,,>8`IA5S'C.`&:P!U@[KAV5B!=@"['[L,>PY M["!V'/L61\2IXLQP[K@('`^7ARO'->'.X@9Q$[AYO!1>"V^#]\.S\=GX$GP] MO@M_`S^.GR=($W0(=H1@0@)A,Z&"T$*X1'A(>$4D$M6)UL0`(I>XB5A!/$Z\ M0APEOB/)D/1)+J1(DI"TDW2$=)YTC_2*3"9KDQW)$60!>2>YD7R1_)C\5H(B M823A)<&6V"A1)=$N,2CQ0A(OJ27I)+E6,D>R7/*DY`W):2F\E+:4BQ13:H-4 ME=0IJ6&I66F*M*FTGW2R=+%TD_15Z4D9K(RVC)L,6R9?YK#,19DQ"D+1H+A0 M6)0ME'K*)5X*5])4"E=8I'5;J4YI5 M5E'V4$Y5WJ]\47E:A:;BJ)*@4J9R5F5*E:)JK\I5+5,]I_J,+DMWHB?1*^@] M]!DU)35/-:%:K5J_VKRZCGJ(>IYZJ_HC#8(&0R-6HTRC6V-&4U735S-7LUGS MOA9>BZ$5K[5/JU=K3EM'.TQ[FW:']J2.G(Z73HY.L\Y#7;*N@VZ:;IWN;3V, M'D,O4>^`WDU]6-]"/UZ_2O^&`6Q@:<`U.&`PL!2]U'HI;VG=TF%#DJ&3889A ML^&H$XT\F%B9))O4F#TQE3%>8YIEVF?YJIF_& M,JLRNVU.-G:?YRF<$RSK*#R^Y:4"Q\+;99=%M\M+2RY%NV6$Y9:5I% M6U5;#3.H#']&,>.*-=K:V7JC]6GK=S:6-@*;$S:_V!K:)MHVV4XNUUG.65Z_ M?,Q.W8YI5VLW8D^WC[8_9#_BH.;`=*AS>.*HXY;PKXNKA6NC:[R;C%N)6Z?;87=T]SKW9?<;#PF.=QWE/M*>W MYV[/82]E+Y97H]?,"JL5ZU?T>).\@[PKO9_XZ/OP?;I\8=\5OGM\'Z[46LE; MV>$'_+S\]O@]\M?Q3_/_/@`3X!]0%?`TT#0P-[`WB!(4%=04]";8.;@D^$&( M;H@PI#M4,C0RM#%T+LPUK#1L9)7QJO6KKH%)64K)2!5(/4@M21-)NTO6DS?&]^ M0SJ4OB:]4T`5_4SU"76%6X6C&?8951EO,T,S3V9)9_&R^K+ULW=D3^2XYWR] M#K6.M:X[5RUW<^[H>J?UM1N@#3$;NC=J;,S?.+[)8]/1S83-B9M_R#/)*\U[ MO25L2U>^=N[]]AOF/_CD^%[,)K129% MY44?BEG%U[XR_:KBJX6=L3O[2RQ+#N["[.+M&MKML/MHJ71I3NG8'M\][67T MLL*RUWNC]EXM7U9>LX^P3[AOI,*GHG._YOY=^S]4QE?>J7*N:JU6JMY1/7>`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`#`/>$\_L*#0IE;F1S=')E86T-96YD;V)J#34U(#`@ M;V)J#3P\+U-T96U6(#$S-B]&;VYT3F%M92]4:6UE7!E+T]B:E-T M;3X^>AJ\#BJ\!4X&KS*&M+@68VLP;/@ M:J`S%6X!6\(/H9&,+F&1GT9(E<&WL+FAF)*U9"12,O"1BJ[@:Z0&&):4J2HR MX.4(8L#+RXH.#L0,)/P\P]D127_M0V2"Y M>EH[40]^NXBZR[X?Q'C5;#91(X/F\##$N$%-X(3Z1E.QB8%"<:.1;!0;S<:P MR=DP13%%,44Q13-%,T4S13-%,T4S13-%,T4S13/%,,4PQ3#%,,4PQ3#%1,HO M<4&1(VI1N\4@3IMN^?5D_OVZ_O(MWGV^?=C<9&'0@CPN3;M5V[GZ=X/J3=KE MUCMQ[/OUN%GOW//M$"2B7C>=J+>WFX5OU\/.73O_>N'J?(3?&+])M&A(^\?U MV]TVNG?4/XKC]J^8]_ZA68D+<=+==?W@L(#'!'U[\:Z[.^=?HH,Z#=BIF/CF MP47,F]01G@5\W1CA1G+E)%=.FI?+`[IPH_O!>G*.$ M3R'YG[X=VFYYUM\Y<>JO;OGDD;OOO7L^.D6RW1!=7.F55P^-?[7[<>@H_ER1 M\9D(L3_OBX>JCHC'3(QW@SVC#"]D]?^%W$W[DHQ]_A8]'YKA>[:_5B5H=8+6 M)&CS!&V1H"T3M%6"UJ;T(JEQ*9V3*:V3^_1.OQ\Z:?8^!7&>(BY2Q&6*N$H1 MVP2QRE+$,D6L4L0Z19S209720;5/!\W[B5+EWJ<@KE+$*:W4'[?RGP`#`+EB MU)<-"F5N9'-T7!E+U!A9V5S+TMI9'-;-#D@,"!273X^#65N9&]B:@TU(#`@ M;V)J#3P\+U-U8G1Y<&4O6$U,+TQE;F=T:"`T,#$U+U1Y<&4O365T861A=&$^ M/G-TFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&UL;G,Z<&1F>#TB:'1T<#HO+VYS M+F%D;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\<&1F>#I#;VUP86YY M/E-E8W5R:71I97,@86YD($5X:&%N9V4@0V]M;6ES#I#;VUP M86YY/@H@("`@("`@("`\<&1F>#I3;W5R8V5-;V1I9FEE9#Y$.C(P,#@P.#`U M,34Q,C4T/"]P9&9X.E-O=7)C94UO9&EF:65D/@H@("`@("`\+W)D9CI$97-C M&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA M<"\Q+C`O(CX*("`@("`@("`@/'AA<#I#&%P.D-R96%T;W)4;V]L/@H@("`@("`@ M("`\>&%P.DUO9&EF>41A=&4^,C`P."TP."TP-50Q,3HT-#HP."TP-#HP,#PO M>&%P.DUO9&EF>41A=&4^"B`@("`@("`@(#QX87`Z0W)E871E1&%T93XR,#`X M+3`X+3`U5#$Q.C0T.C`S+3`T.C`P/"]X87`Z0W)E871E1&%T93X*("`@("`@ M("`@/'AA<#I-971A9&%T841A=&4^,C`P."TP."TP-50Q,3HT-#HP."TP-#HP M,#PO>&%P.DUE=&%D871A1&%T93X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^ M"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&%P34TZ&%P34TZ"UD969A=6QT(B\^"B`@("`@("`@("`@(#PO2A3 M96-U&AA;F=E($-O;6UI')E9@T* M,"`T-PT*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`W,3F4@-#<^/@T* -----END PRIVACY-ENHANCED MESSAGE-----